Triagonist-treated mice showed a slight reduction of body weight along treatment (2%) and improved glucose tolerance, although no changes were detected in the other metabolic parameters analyzed (Fig
It may turn out that for one of these many, many peptides, well see benefit, Amdur says
Semaglutide not only consistently reduces energy intake (Wilding et al., 2021)
Allelic Variant in the Glucagon-like Peptide 1 Receptor Gene Associated with Greater Effect of Liraglutide and Exenatide on Gastric Emptying: A Pilot Pharmacogenetics Study. Neurogastroenterology and Motility: The Official Journal of the European Gastrointestinal Motility Society, vol
However, this was an observational study, so it does not establish causality, and GLP-1 agents should not yet be considered primary treatments for depression or anxiety, he told Healthline